Clinical Trial Update: Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a booster dose of pneumococcal vaccine formulations in young adults has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal

Drugs mentioned

• Pneumococcal vaccine formulations (Streptococcus pneumoniae vaccine formulations)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 2 | Status: COMPLETED | Results posted: 2017-07-19